The microbiome and human cancer

Author:

Sepich-Poore Gregory D.1ORCID,Zitvogel Laurence2345ORCID,Straussman Ravid6ORCID,Hasty Jeff178ORCID,Wargo Jennifer A.910ORCID,Knight Rob11112ORCID

Affiliation:

1. Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.

2. Gustave Roussy Cancer Campus (GRCC), Equipe Labellisée–Ligue Nationale contre le Cancer, Villejuif, France.

3. Institut National de la Santé et de la Recherche Medicale (INSERM) U1015, Villejuif, France.

4. Université Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.

5. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France.

6. Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

7. BioCircuits Institute, University of California, San Diego, La Jolla, CA, USA.

8. Molecular Biology Section, Division of Biological Science, University of California, San Diego, La Jolla, CA, USA.

9. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

10. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

11. Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA.

12. Department of Computer Science and Engineering, University of California, San Diego, La Jolla, CA, USA.

Abstract

Separating microbes and cancers The role of microorganisms in causing and sustaining cancers has been in dispute for centuries. Through the lens of gut- and tumor-associated microbes, Sepich-Poore et al. review our current understanding of the microbiota in cancer, building a “microbially conscious” framework. The authors argue that humans should be considered as a meta-organism, but how our microbiota influences cancer is still not well understood mechanistically. Nevertheless, advances in microbiome research are improving our understanding of immuno-oncology and driving new diagnostic and therapeutic approaches. Science , this issue p. eabc4552

Funder

National Cancer Institute

RHU Torino Lumière

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference179 articles.

1. B. Ebbell The Papyrus Ebers: The Greatest Egyptian Medical Document (Levin & Munksgaard 1937).

2. Dr William Coley and tumour regression: A place in history or in the future;Hoption Cann S. A.;Postgrad. Med. J.,2003

3. Aus der Sitzung der medicinischen Section vom 13 November 1867;Busch W.;Berl Klin Wochenschr,1868

4. Ueber die Züchtung der Erysipelkokken auf künstlichem Nährboden und ihre Uebertragbarkeit auf den Menschen

5. Coley's toxins in perspective

Cited by 488 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3